Drug maker Khandelwal Laboratories is in advanced talks to sell its oncology portfolio to Italy’s Menarini for close to Rs170 crore, two people familiar with the development said.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
